Get answers in 25 minutes or less from world-class experts and earn CME/CE credit with CME in Minutes: Education in Ophthalmology by Answers in CME. Benefit from digests of latest advancements, thoughtful case studies, and nuanced perspectives. Inspiring and engaging programs designed for busy healthcare professionals to cover the diagnosis, treatment, follow-up, and clinical management of conditions in ophthalmology. Earning your CME/CE credit has never been faster or easier. Download the URL for each individual program to request continuing education credit or access the slides.
Bridging Clinical Trial and Real-World Evidence in Retinal Diseases: Updated Strategies With Anti-VEGF Therapies
Please visit answersincme.com/BWG860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Ferhina Ali, MD, MPH, FASRS. In this activity, an expert in retinal diseases discusses integrating clinical trial and real-world evidence into the use of newer-generation anti–vascular endothelial growth factor (VEGF) agents. Upon completion of this activity, participants should be better able to: Review the role of different types of data in informing management of retinal diseases; Assess clinical trial data and real-world evidence supporting the use of newer-generation anti-VEGF agents for retinal diseases; and Propose treatment plans for the management of retinal diseases based on clinical trial data and real-world evidence.
5 Jun 2026
Jordana Goren Fein, MD, MS - Bringing Retinal Vein Occlusion Into Focus: Case-Based Approaches to Optimizing Management With Anti-VEGF Therapies
Please visit answersincme.com/ADC860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Jordana Goren Fein, MD, MS. In this activity, an expert in retinal vein occlusion (RVO) reviews diagnostic best practices, newer-generation anti-VEGF therapies, and patient-centered management strategies. Upon completion of this activity, participants should be better able to: Describe best practices for diagnosing RVO; Differentiate between the clinical profiles of available newer-generation intravitreal anti-VEGF therapies for macular edema (ME) secondary to RVO; and Propose optimized, patient-centered treatment plans for the multidisciplinary management of patients with RVO.
31 Mar 2026
Taking the Long View on DME Management: Practical Approaches With Long-Acting Anti-VEGF Agents
Please visit answersincme.com/AGN860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Ferhina Ali, MD, MPH, FASRS. In this activity, an expert in retinal diseases discusses anti-VEGF treatment of diabetic macular edema. Upon completion of this activity, participants should be better able to: Recognize factors that contribute to patients' treatment burden with intravitreal anti–vascular endothelial growth factor (VEGF) therapies for diabetic macular edema (DME); Assess the clinical profiles of long-acting intravitreal anti-VEGF agents for DME; and Recommend individualized strategies to enhance long-term treatment outcomes for patients with DME.
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
3.7 / 5
3 ratings
Spotify
5.0 / 5
1 ratings
Contact CME in Minutes: Education in Ophthalmology
Guest appearances
Does not typically book guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of CME in Minutes: Education in Ophthalmology?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
